Meta description: The UNos integrated E Nose trial for head and neck cancer has completed recruitment, signaling regulatory readiness questions for multi channel electronic nose devices.
Publication date context: February 19, 2026. This report summarizes a clinical trial listing and sponsor details for an artificial or electronic nose device in cancer detection. The sponsor is the Institute of Oncology Ljubljana and the study identifier is NCT07419113 on ClinicalTrials.gov. The source text notes the trial is listed as completed, but provides no published results in the excerpt.
In this article
What is UNos and what is the trial status?
UNos describes an integrated multi channel artificial nose used to detect signals associated with cancer in patients with head and neck cancer. The device is described as an E Nose or electronic nose in the trial listing. The trial is identified as completed and the sponsor is the Institute of Oncology Ljubljana. The ClinicalTrials.gov entry is NCT07419113.
How does the UNos E Nose operate?
The listing implies a sensing array that analyzes volatile compounds or breath like samples to identify cancer related patterns. The exact algorithms and performance metrics are not disclosed in the source text.
What regulatory context applies to this device in trials?
The provided record does not indicate regulatory approval or clearance for UNos. It shows a sponsor and a completed trial, signaling that the device is under investigation and that future regulatory submissions may follow data review and validation.
What do we know about safety and performance from the available data?
No efficacy or safety outcomes are published in the material provided. The available information centers on device type, trial scope and sponsor identity rather than study results or safety conclusions.
What are the implications for practice and future research?
If later results demonstrate robust performance in detecting cancer signals, developers and sponsors may pursue regulatory filings for this multi channel E Nose concept. Clinicians and researchers should monitor official updates from the sponsor and the ClinicalTrials.gov listing for data releases.
FAQ
- 1. What is UNos? The UNos system is described as an integrated multi channel artificial nose used for cancer detection in head and neck cancer.
- 2. Who sponsors the trial? The Institute of Oncology Ljubljana is listed as the sponsor.
- 3. What is the trial status? The record shows completed status for NCT07419113.
Conclusion
The UNos trial status indicates a completed study for an E Nose device in head and neck cancer. The next steps involve data release and potential regulatory discussions. Readers should monitor official sources for results and any regulatory submissions.
Disclaimer
This information is intended for professionals. It is not legal advice. For regulatory interpretation please consult a qualified expert.
Announcement Link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07419113?term=medical+device